Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126853071 | 12685307 | 1 | I | 20150701 | 20150713 | 20160825 | 20160825 | PER | US-NOVOPROD-456970 | NOVO NORDISK | 58.00 | YR | A | F | Y | 0.00000 | 20160825 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126853071 | 12685307 | 1 | PS | VICTOZA | LIRAGLUTIDE | 1 | Subcutaneous | 1.2 MG, QD | DS6K516 | 22341 | 1.2 | MG | SOLUTION FOR INJECTION | QD | |||||
126853071 | 12685307 | 2 | SS | VICTOZA | LIRAGLUTIDE | 1 | Subcutaneous | 0.6 MG, QD | 22341 | .6 | MG | SOLUTION FOR INJECTION | QD | ||||||
126853071 | 12685307 | 3 | SS | VICTOZA | LIRAGLUTIDE | 1 | Subcutaneous | 1.2 MG, QD | 22341 | 1.2 | MG | SOLUTION FOR INJECTION | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126853071 | 12685307 | 1 | Type 2 diabetes mellitus |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126853071 | 12685307 | Eructation | |
126853071 | 12685307 | Haematemesis | |
126853071 | 12685307 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |